Patents by Inventor Meirong GU

Meirong GU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220118075
    Abstract: The present invention provides a Hansenula engineering fungus that efficiently expresses CA10 virus-like particles and use thereof. The engineering fungus comprises a recombinant vector carrying P1 and 3CD genes of the CA10 virus, and the starting strain of the engineering fungus is uracil auxotroph. The Hansenula AU-0501, P1 and 3CD genes are optimized according to preferred codons of Hansenula. The present invention also provides a preparation method of CA10 virus-like particles, comprising: culturing engineering fungi, expressing CA10 virus-like particles, and separating and purifying virus-like particles by ultrafiltration and three-step chromatography.
    Type: Application
    Filed: September 3, 2020
    Publication date: April 21, 2022
    Inventors: Guoshun Li, Meirong Gu, Lin Guo, Wei Jian, Junjie Liu, Haifeng Xiao, Gaimei Zhang, Lili Zhao, Xuechao Xie, Lei Chen, Yingzhi Xu, Jiankai Liu
  • Patent number: 10987416
    Abstract: The present invention provides a method for purifying an EV71 virus-like particle and a method for preparing a vaccine thereof. The virus-like particle is obtained by performing high density fermentation cultivation on recombinantly engineered bacteria; inducing expression of the EV71 virus-like particle protein expression using methanol; collecting the bacteria by centrifugation and performing high-pressure homogenization for disruption; performing precipitation on the supernatant with ammonium sulfate; and purifying by redissolution, ultrafiltration, ion exchange chromatography, molecular sieve chromatography, hydroxyapatite chromatography, etc.
    Type: Grant
    Filed: December 28, 2016
    Date of Patent: April 27, 2021
    Assignee: Beijing Minhai Biotechnology Co., Ltd.
    Inventors: Guoshun Li, Meirong Gu, Jiankai Liu, Lin Guo, Lei Chen, Gaimei Zhang, Yingzhi Xu, Jin Li, Haifeng Xiao
  • Publication number: 20190240314
    Abstract: The present invention provides a method for purifying an EV71 virus-like particle and a method for preparing a vaccine thereof. The virus-like particle is obtained by performing high density fermentation cultivation on recombinantly engineered bacteria; inducing expression of the EV71 virus-like particle protein expression using methanol; collecting the bacteria by centrifugation and performing high-pressure homogenization for disruption; performing precipitation on the supernatant with ammonium sulfate; and purifying by redissolution, ultrafiltration, ion exchange chromatography, molecular sieve chromatography, hydroxyapatite chromatography, etc.
    Type: Application
    Filed: December 28, 2016
    Publication date: August 8, 2019
    Applicant: BEIJING MINHAI BIOTECHNOLOGY CO., LTD.
    Inventors: Guoshun LI, Meirong GU, Jiankai LIU, Lin GUO, Lei CHEN, Gaimei ZHANG, Yingzhi XU, Jin LI, Haifeng XIAO
  • Patent number: 9782471
    Abstract: The present invention provides EV71 virus-like particles and a preparation method and application thereof. The method comprises: connecting a P1 protein gene and a 3CD protease gene of an EV71 virus with a PMV plasmid to construct a PMV-P1-3CD recombinant expression plasmid; then transforming a Hansenula polymorpha AU-0501 expression strain with the PMV-P1-3CD recombinant expression plasmid to obtain an AU-PMV-P1-3CD recombinant expression strain; fermenting and culturing the recombinant expression strain, and inducing the recombinant expression strain to express the EV71 virus-like particle protein with methanol; centrifuging and collecting mycelia for homogeneous breakage at a high pressure; and purifying the supernatant through ion-exchange chromatography, hydrophobic chromatography, and molecular sieve chromatography, so as to obtain EV71 virus-like particles.
    Type: Grant
    Filed: April 25, 2014
    Date of Patent: October 10, 2017
    Assignee: BEIJING MINHAI BIOTECHNOLOGY CO., LTD.
    Inventors: Meirong Gu, Wenjin Wei, Jiankai Liu, Linlin Song, Shanshan Xu, Guoshun Li, Lin Guo
  • Publication number: 20160166675
    Abstract: The present invention provides EV71 virus-like particles and a preparation method and application thereof. The method comprises: connecting a P1 protein gene and a 3CD protease gene of an EV71 virus with a PMV plasmid to construct a PMV-P1-3CD recombinant expression plasmid; then transforming a Hansenula polymorpha AU-0501 expression strain with the PMV-P1-3CD recombinant expression plasmid to obtain an AU-PMV-P1-3CD recombinant expression strain; fermenting and culturing the recombinant expression strain, and inducing the recombinant expression strain to express the EV71 virus-like particle protein with methanol; centrifuging and collecting mycelia for homogeneous breakage at a high pressure; and purifying the supernatant through ion-exchange chromatography, hydrophobic chromatography, and molecular sieve chromatography, so as to obtain EV71 virus-like particles.
    Type: Application
    Filed: April 25, 2014
    Publication date: June 16, 2016
    Inventors: Meirong GU, Wenjin WEI, Jiankai LIU, Linlin SONG, Shanshan XU, Guoshun LI, Lin GUO